This is the authors' abstract. We don't add key points for this paper.
In this biologically high-risk group, pCR differs by receptor subset. pCR is more highly predictive of RFS within every established receptor subset than overall, demonstrating that the extent of outcome advantage conferred by pCR is specific to tumor biology.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Esserman et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: